Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease

Objective Apathy is a common neuropsychological symptom in Alzheimer’s disease (AD), and previous studies demonstrated that neuronal loss and network disruption in some brain regions play pivotal roles in the pathogenesis of apathy. However, contributions of tau and amyloid-β (Aβ) depositions, pathological hallmarks of AD, to the manifestation of apathy remain elusive. Methods Seventeen patients with AD underwent positron emission tomography (PET) with 11C-pyridinyl-butadienyl-benzothiazole 3 (11C-PBB3) and 11C-Pittsburgh compound-B (11C-PiB) to estimate tau and Aβ accumulations using standardised uptake value ratio (SUVR) images. 11C-PBB3 and 11C-PiB SUVR were compared between AD patients with high and low Apathy Scale (AS) scores. Additionally, volumetric and diffusion tensor MRI was performed in those areas where any significant difference was observed in PET analyses. Correlation and path analyses among AS and estimated imaging parameters were also conducted. Results AD patients with high AS scores showed higher 11C-PBB3 SUVR in the orbitofrontal cortex (OFC) than those with low AS scores, while 11C-PiB SUVR in any brain regions did not differ between them. Elevated 11C-PBB3 SUVR in OFC, decreased OFC thickness and decreased fractional anisotropy (FA) in the uncinate fasciculus (UNC), which is structurally connected to OFC, correlated significantly with increased scores of the AS. Path analysis indicated that increased 11C-PBB3 SUVR in OFC affects apathy directly and through reduction of OFC thickness and subsequent decrease of FA in UNC. Conclusions The present findings suggested that tau pathology in OFC may provoke focal neurotoxicity in OFC and the following disruption of the OFC-UNC network, leading to the emergence and progression of apathy in AD.

[1]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  Virginia M. Y. Lee,et al.  Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies , 2017, Brain : a journal of neurology.

[3]  Ming-Rong Zhang,et al.  Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3-PET study , 2016, Alzheimer's & dementia.

[4]  Eric E. Smith,et al.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment , 2016, Alzheimer's & Dementia.

[5]  Ming-Rong Zhang,et al.  Identification of a major radiometabolite of [11C]PBB3. , 2015, Nuclear medicine and biology.

[6]  P. Eslinger,et al.  Apathy in Frontotemporal Degeneration: Neuroanatomical Evidence of Impaired Goal-directed Behavior , 2015, Front. Hum. Neurosci..

[7]  M. Husain,et al.  Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes , 2015, Brain : a journal of neurology.

[8]  Ming-Rong Zhang,et al.  PET Quantification of Tau Pathology in Human Brain with 11C-PBB3 , 2015, The Journal of Nuclear Medicine.

[9]  Matthew L Senjem,et al.  Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span. , 2015, JAMA neurology.

[10]  Hitoshi Shimada,et al.  Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  Keith A. Johnson,et al.  Apathy is associated with increased amyloid burden in mild cognitive impairment. , 2013, The Journal of neuropsychiatry and clinical neurosciences.

[12]  J. Trojanowski,et al.  Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls , 2013, Neuron.

[13]  I. Olson,et al.  Dissecting the uncinate fasciculus: disorders, controversies and a hypothesis. , 2013, Brain : a journal of neurology.

[14]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[15]  K. Ahn,et al.  Apathy and White Matter Integrity in Alzheimer’s Disease: A Whole Brain Analysis with Tract-Based Spatial Statistics , 2013, PloS one.

[16]  T. Schweizer,et al.  Delusions Increase Functional Impairment in Alzheimer’s Disease , 2012, Dementia and Geriatric Cognitive Disorders.

[17]  A. Simmons,et al.  Apathy and cortical atrophy in Alzheimer's disease , 2011, International journal of geriatric psychiatry.

[18]  Deborah M. Clawson,et al.  Regional Brain Atrophy and Impaired Decision Making on the Balloon Analog Risk Task in Behavioral Variant Frontotemporal Dementia , 2011, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[19]  F. Stella,et al.  Apathy in Alzheimer’s disease: Contribution to a clinical view on progression of dementia , 2010, Dementia & neuropsychologia.

[20]  K. Kiuchi,et al.  Fractional Anisotropy–Threshold Dependence in Tract-Based Diffusion Tensor Analysis: Evaluation of the Uncinate Fasciculus in Alzheimer Disease , 2009, American Journal of Neuroradiology.

[21]  Takahira Yamauchi,et al.  Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: A diffusion tensor tractography study , 2009, Brain Research.

[22]  P. Robert,et al.  Patient and Caregiver Perspectives of Quality of Life in Dementia , 2008, Dementia and Geriatric Cognitive Disorders.

[23]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[24]  J. Starr,et al.  Relationship between Behavioural and Psychological Symptoms of Dementia and Cognition in Alzheimer’s Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[25]  R. Bullock,et al.  Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase. , 2007, Current Alzheimer research.

[26]  Sandra E Black,et al.  A SPECT Study of Apathy in Alzheimer’s Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[27]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[28]  B. Dubois,et al.  Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. , 2006, Cerebral cortex.

[29]  Karl Herholz,et al.  Regional cerebral metabolism in early Alzheimer’s disease with clinically significant apathy or depression , 2005, Biological Psychiatry.

[30]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[31]  Y. Ouchi,et al.  Vitality Index as a useful tool to assess elderly with dementia , 2002 .

[32]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[33]  T. Robbins,et al.  Decision making and neuropsychiatry , 2001, Trends in Cognitive Sciences.

[34]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  David N. Kennedy,et al.  MRI-Based Topographic Parcellation of Human Cerebral White Matter I. Technical Foundations , 1999, NeuroImage.

[36]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[37]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[40]  R. Castellani,et al.  Alzheimer disease. , 2010, Disease-a-month : DM.

[41]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[42]  Kazunori Okada,et al.  Assessment of motivational loss in post-stroke patients using the Japanese version of Stark-stein's Apathy scale , 1998 .

[43]  H. Mayberg,et al.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[44]  R. Marin,et al.  Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[45]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.